Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

National News

Cleveland: Hospital Launches Study of Smallpox Vaccine That's Safe for AIDS Patients

November 22, 2002

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

Researchers at University Hospitals in Cleveland are set to test a new smallpox vaccine in a study to measure side effects and immune response in people with AIDS. If results are favorable, millions of immune-compromised individuals could be vaccinated against smallpox. The current vaccine, Dryvax, is not recommended for people with weak immune systems -- including diabetics, transplant recipients, elderly persons, small children, and HIV-positive people -- because they are more susceptible to its dangerous side effects.

Five other US hospitals are also participating in the study, which will enroll about 88 people, said Dr. Hernan Valdez, assistant professor of medicine at Case Western Reserve University and part of the AIDS Clinical Trials Unit at University Hospitals. The Food and Drug Administration must approve the protocol before the study can begin, which could take up to 30 days, said Dr. Lawrence Fox, medical officer for the HIV Research Branch of the National Institute for Allergy and Infectious Diseases. NIAID is sponsoring the study.

The study will test the safety and effectiveness of the modified Ankara vaccine (MVA). MVA has never undergone widespread testing in the United States, but Valdez said it produced only minor side effects in a recent German study of HIV-positive individuals. Soreness at the vaccination site was the primary side effect. In contrast, Dryvax, which is made from cow guts, can cause severe skin problems, blindness and brain inflammation. For every 1 million people vaccinated, 15 develop life-threatening problems and at least one dies. But while MVA is considered safer than Dryvax, scientists are not sure MVA alone can prevent smallpox. Dryvax, which is credited with eradicating smallpox throughout the world, is the only smallpox vaccine available in the United States.

Back to other CDC news for November 22, 2002

Previous Updates

Adapted from:
Associated Press
11.21.02

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
Smallpox Basics
More News and Research on Smallpox and HIV

Tools
 

Advertisement